OBJECTIVE: To evaluate the longitudinal influence of family history (FH) of Alzheimer disease (AD) and apolipoprotein E ε4 allele (APOE4) on brain atrophy and cognitive decline over 4 years among asymptomatic middle-aged individuals. METHODS: Participants were cognitively healthy adults with (FH+) (n = 60) and without (FH-) (n = 48) a FH of AD (mean age at baseline 54 years) enrolled in the Wisconsin Registry for Alzheimer's Prevention. They underwent APOE genotyping, cognitive testing, and an MRI scan at baseline and 4 years later. A covariate-adjusted voxel-based analysis interrogated gray matter (GM) modulated probability maps at the 4-year follow-up visit as a function of FH and APOE4. We also examined the influence of parent of origin on GM atrophy. Parallel analyses investigated the effects of FH and APOE4 on cognitive decline. RESULTS: Neither FH nor APOE4 had an effect on regional GM or cognition at baseline. Longitudinally, a FH × APOE4 interaction was found in the right posterior hippocampus, which was driven by a significant difference between the FH+ and FH- subjects who were APOE4-. In addition, a significant FH main effect was observed in the left posterior hippocampus. No significant APOE4 main effects were detected. Persons with a maternal history of AD were just as likely as those with a paternal history of AD to experience posterior hippocampal atrophy. There was no longitudinal decline in cognition within the cohort. CONCLUSION: Over a 4-year interval, asymptomatic middle-aged adults with FH of AD exhibit significant atrophy in the posterior hippocampi in the absence of measurable cognitive changes. This result provides further evidence that detectable disease-related neuroanatomic changes do occur early in the AD pathologic cascade.
OBJECTIVE: To evaluate the longitudinal influence of family history (FH) of Alzheimer disease (AD) and apolipoprotein E ε4 allele (APOE4) on brain atrophy and cognitive decline over 4 years among asymptomatic middle-aged individuals. METHODS:Participants were cognitively healthy adults with (FH+) (n = 60) and without (FH-) (n = 48) a FH of AD (mean age at baseline 54 years) enrolled in the Wisconsin Registry for Alzheimer's Prevention. They underwent APOE genotyping, cognitive testing, and an MRI scan at baseline and 4 years later. A covariate-adjusted voxel-based analysis interrogated gray matter (GM) modulated probability maps at the 4-year follow-up visit as a function of FH and APOE4. We also examined the influence of parent of origin on GM atrophy. Parallel analyses investigated the effects of FH and APOE4 on cognitive decline. RESULTS: Neither FH nor APOE4 had an effect on regional GM or cognition at baseline. Longitudinally, a FH × APOE4 interaction was found in the right posterior hippocampus, which was driven by a significant difference between the FH+ and FH- subjects who were APOE4-. In addition, a significant FH main effect was observed in the left posterior hippocampus. No significant APOE4 main effects were detected. Persons with a maternal history of AD were just as likely as those with a paternal history of AD to experience posterior hippocampal atrophy. There was no longitudinal decline in cognition within the cohort. CONCLUSION: Over a 4-year interval, asymptomatic middle-aged adults with FH of AD exhibit significant atrophy in the posterior hippocampi in the absence of measurable cognitive changes. This result provides further evidence that detectable disease-related neuroanatomic changes do occur early in the AD pathologic cascade.
Authors: Reisa A Sperling; Paul S Aisen; Laurel A Beckett; David A Bennett; Suzanne Craft; Anne M Fagan; Takeshi Iwatsubo; Clifford R Jack; Jeffrey Kaye; Thomas J Montine; Denise C Park; Eric M Reiman; Christopher C Rowe; Eric Siemers; Yaakov Stern; Kristine Yaffe; Maria C Carrillo; Bill Thies; Marcelle Morrison-Bogorad; Molly V Wagster; Creighton H Phelps Journal: Alzheimers Dement Date: 2011-04-21 Impact factor: 21.566
Authors: L Adrienne Cupples; Lindsay A Farrer; A Dessa Sadovnick; Norman Relkin; Peter Whitehouse; Robert C Green Journal: Genet Med Date: 2004 Jul-Aug Impact factor: 8.822
Authors: Chengjie Xiong; Catherine M Roe; Virginia Buckles; Anne Fagan; David Holtzman; David Balota; Janet Duchek; Martha Storandt; Mark Mintun; Elizabeth Grant; Abraham Z Snyder; Denise Head; Tammie L S Benzinger; Joseph Mettenburg; John Csernansky; John C Morris Journal: Arch Neurol Date: 2011-10
Authors: E M Reiman; R J Caselli; L S Yun; K Chen; D Bandy; S Minoshima; S N Thibodeau; D Osborne Journal: N Engl J Med Date: 1996-03-21 Impact factor: 91.245
Authors: C DeCarli; D G Murphy; J A Gillette; J V Haxby; D Teichberg; M B Schapiro; B Horwitz Journal: AJNR Am J Neuroradiol Date: 1994-04 Impact factor: 3.825
Authors: Ozioma C Okonkwo; Guofan Xu; Jennifer M Oh; N Maritza Dowling; Cynthia M Carlsson; Catherine L Gallagher; Alex C Birdsill; Matthew Palotti; Whitney Wharton; Bruce P Hermann; Asenath LaRue; Barbara B Bendlin; Howard A Rowley; Sanjay Asthana; Mark A Sager; Sterling C Johnson Journal: Cereb Cortex Date: 2012-12-12 Impact factor: 5.357
Authors: Christine L Tardif; Gabriel A Devenyi; Robert S C Amaral; Sandra Pelleieux; Judes Poirier; Pedro Rosa-Neto; John Breitner; M Mallar Chakravarty Journal: Hum Brain Mapp Date: 2017-11-21 Impact factor: 5.038
Authors: Stephanie A Schultz; Jordan Larson; Jennifer Oh; Rebecca Koscik; Maritza N Dowling; Catherine L Gallagher; Cynthia M Carlsson; Howard A Rowley; Barbara B Bendlin; Sanjay Asthana; Bruce P Hermann; Sterling C Johnson; Mark Sager; Asenath LaRue; Ozioma C Okonkwo Journal: Brain Imaging Behav Date: 2015-12 Impact factor: 3.978
Authors: Andrew J Aschenbrenner; David A Balota; Brian A Gordon; Roger Ratcliff; John C Morris Journal: Neuropsychology Date: 2016-02 Impact factor: 3.295
Authors: Rebecca L Koscik; Asenath La Rue; Erin M Jonaitis; Ozioma C Okonkwo; Sterling C Johnson; Barbara B Bendlin; Bruce P Hermann; Mark A Sager Journal: Dement Geriatr Cogn Disord Date: 2014-02-20 Impact factor: 2.959
Authors: Danielle L Brokaw; Ignazio S Piras; Diego Mastroeni; Daniel J Weisenberger; Jennifer Nolz; Elaine Delvaux; Geidy E Serrano; Thomas G Beach; Matthew J Huentelman; Paul D Coleman Journal: Neurobiol Aging Date: 2020-07-03 Impact factor: 4.673
Authors: Sterling C Johnson; Bradley T Christian; Ozioma C Okonkwo; Jennifer M Oh; Sandra Harding; Guofan Xu; Ansel T Hillmer; Dustin W Wooten; Dhanabalan Murali; Todd E Barnhart; Lance T Hall; Annie M Racine; William E Klunk; Chester A Mathis; Barbara B Bendlin; Catherine L Gallagher; Cynthia M Carlsson; Howard A Rowley; Bruce P Hermann; N Maritza Dowling; Sanjay Asthana; Mark A Sager Journal: Neurobiol Aging Date: 2013-10-23 Impact factor: 4.673
Authors: Ozioma C Okonkwo; Jennifer M Oh; Rebecca Koscik; Erin Jonaitis; Caitlin A Cleary; N Maritza Dowling; Barbara B Bendlin; Asenath Larue; Bruce P Hermann; Todd E Barnhart; Dhanabalan Murali; Howard A Rowley; Cynthia M Carlsson; Catherine L Gallagher; Sanjay Asthana; Mark A Sager; Brad T Christian; Sterling C Johnson Journal: J Int Neuropsychol Soc Date: 2014-03-12 Impact factor: 2.892
Authors: Siobhan M Hoscheidt; Erika J Starks; Jennifer M Oh; Henrik Zetterberg; Kaj Blennow; Rachel A Krause; Carey E Gleason; Luigi Puglielli; Craig S Atwood; Cynthia M Carlsson; Sanjay Asthana; Sterling C Johnson; Barbara B Bendlin Journal: J Alzheimers Dis Date: 2016-04-12 Impact factor: 4.472